Pacylex Pharmaceuticals develops a precision medicine solution for multiple common cancers.
Pacylex has raised $1.4M in total funding. The most recent round was Grant. The last funding was announced in October 2022.
Pacylex's investors include U.S. Department of War, VA Angels, Greenfire Bio.
Pacylex is headquartered in Edmonton, Canada.
Pacylex Pharmaceuticals develops a precision medicine solution for multiple common cancers.
Pacylex is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Pacylex — Funding & Investors." VCBacked, October 11, 2022, https://www.vcbacked.co/company/pacylex. Accessed November 13, 2026.
VCBacked. (2022). Pacylex — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/pacylex
{{cite web |title=Pacylex — Funding & Investors |url=https://www.vcbacked.co/company/pacylex |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Pacylex? Request a listing update